Amphenol

Amphenol (APH.US) staged a strong single-session rally, closing up 4.98% at $158.01, driven primarily by continued robust demand from AI-related businesses. The company's Q1 2026 revenue surged 58.39% YoY to $7.62 billion, while operating income soared 84.18% YoY to $2.08 billion, underscoring the powerful tailwind from AI and data center markets. Despite the day's gain, the stock remains 11.49% below its 52-week high of $178.52 and trades under its 20-day moving average of $160.96, though well above the 60-day MA of $148.26, with a YTD advance of 13.1%. Recent analyst commentary highlighted that the AI-fueled record quarter and progress in CCS integration could reshape the narrative. However, post-market trading saw the stock slip to $151.78, suggesting near-term profit-taking pressure.

Amphenol (APH.US) experienced a sharp intraday decline, primarily driven by the Nvidia Kyber delay to 2028, which dampened sentiment across the supply chain, compounded by a 4.48% overnight after-hours drop. The stock fell from a pre-market high of $166.665 to a low of $158.450 by 10:11 ET, representing a 4.9% intraday loss and an 11.19% retreat from its 52-week high of $178.52. Despite strong Q1 results with revenue surging 58.39% YoY to $7.62 billion and net profit up 26.46% to $933 million, the elevated valuation made the stock vulnerable to AI demand concerns. The price has fallen below the 20-day moving average ($160.837), though it remains up 13.47% YTD. While late-day buying pushed the stock to $166.630 in after-hours trading, suggesting some dip-buying interest.

Amphenol shares suffered a sharp decline during regular trading, closing at $163.655, down approximately 4.97% from the previous close of $172.22, erasing earlier pre-market gains that saw prices between $170.00 and $174.25. The stock hit an intraday high of $172.885 before trending lower to $163.53, its session low. After reaching a 52-week high of $178.52 earlier this week, the current price is roughly 8.33% below that peak but still holds above both the 20-day moving average ($158.80) and 60-day moving average ($146.06), with a year-to-date gain of 17.14%. Recent earnings reported strong fundamental momentum: Q1 operating revenue surged 58.39% year-over-year to $7.62 billion, and net profit rose 26.46% to $933 million, though the net profit margin of 12.24% in Q1 lagged Q4's 18.57%. Market sentiment was dented by reports that the stock was excluded from an analyst preferred list, undermining investor confidence; post-market trading saw shares fall another 3.04% to $172.79. In contrast, a prior analyst consensus maintained a 'Moderate Buy' rating, and the stock had gained 3.43% on June 15.